Sulfonic acid polymers as a new class of human immunodeficiency virus inhibitors

Antiviral Research

Volumn 18, Issue 2, 1992, Pages 139-150

  Mohan, Prem ^a   Schols, Dominique ^b   Baba, Masanori ^c   De Clercq, Erik ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

CD4 receptor; Glycoprotein gp120; Human immunodeficiency virus; Sulfonic acid polymer; Syncytium formation

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; POLY(2 ACRYLAMIDO 2 METHYL 1 PROPANESULFONIC ACID); POLY(VINYLSULFONATE SODIUM); POLYANETHOLESULFONIC ACID; POLYMER; POLYSTYRENESULFONIC ACID; RNA DIRECTED DNA POLYMERASE; SULFONIC ACID DERIVATIVE; SURAMIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOLOGY; CYTOPATHOGENIC EFFECT; GIANT CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; PRIORITY JOURNAL;

ANTIGENS, CD4; ANTIVIRAL AGENTS; CELLS, CULTURED; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOPROTEINS; HIV; HIV-1; HIV-2; POLYMERS; POLYVINYLS; REVERSE TRANSCRIPTASE INHIBITORS; RNA-DIRECTED DNA POLYMERASE; SULFONIC ACIDS; SUPPORT, NON-U.S. GOV'T; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 0026605112     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(92)90034-3     Document Type: Article

References (37)

1. Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) in vitro
2. Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation
3. Novel sulfated polysaccharides: Dissociation of anti-human immunodeficiency virus activity from antithrombin activity
4. Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV)
5. Isolation of a T cell lymphotropic virus from a patient at risk for the acquired immunodeficiency syndrome (AIDS)
6. Metabolism of 2-naphthylamine sulfonic acids
7. Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogues: Direct correlation of antiviral potency with molecular weight
8. Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses
9. Basic approaches to anti-retroviral treatment
10. Frequent detection and isolation of pathogenic retroviruses (HTLV-III) from patients with AIDS and at risk from AIDS
11. AIDS-antiviral sulfolipids from cyanobacteria (bluegreen algae)
12. Pharmacokinetic analysis of dextran sulfate in rats as pertains to its clinical usefulness for therapy of HIV infection
13. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by suramin-related compounds
14. Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in clone cells of human leukemic T-cell line Molt-4
15. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS
16. Dextran sulfate is poorly absorbed after oral administration
17. Metabolism of linear alkylate sulfonate and alkyl benzene sulfonate in albino rats
18. Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III
19. Type C virus producing cell lines derived from adult T cell leukemia
20. Potential anti-AIDS agents
21. Anti-HIV-1 and HIV-2 activity of napthalenedisulfonic acid derivatives
22. Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus
23. Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
24. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS
25. Anthraquinones as a new class of antiviral agents against human immunodeficiency virus
26. + cells
27. + cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry
28. Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor
29. Dextran sulphate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein of persistently HIV-1 infected cells
30. + cells following their fusion with HIV-infected cells
31. Sulphated polymers are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, respiratory syncytial virus, and toga-, arena- and retroviruses
32. Sulfated cyclodextrins are potent anti-HIV agents acting synergistically with 2′,3′-dideoxynucleoside analogues
33. Selective inhibitory activity of polycarboxylates derived from phenolic compounds against human immunodeficiency virus replication
34. Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein
35. Lignosulfonate a water soluble lignin from the waste liquor of the pulping process inhibits the infectivity and cytopathic effects of human immunodeficiency virus in vitro
36. Detoxication mechanisms